Literature DB >> 22904124

Association of dialysis modality with risk for infection-related hospitalization: a propensity score-matched cohort analysis.

Jean-Philippe Lafrance1, Elham Rahme, Sameena Iqbal, Naoual Elftouh, Michel Vallée, Louis-Philippe Laurin, Denis Ouimet.   

Abstract

BACKGROUND AND OBJECTIVES: Peritonitis is a well known complication of peritoneal dialysis (PD), whereas in hemodialysis (HD), bacteremia can be life threatening. Whether patients undergoing PD have higher risk than HD patients for infection-related hospitalizations (IRH) remains unknown. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A propensity score-matched retrospective cohort of patients undergoing long-term dialysis between January 2001 and December 2007 was assembled. Propensity scores were calculated using multivariable (demographic characteristics, smoking, body mass index, comorbid conditions, and laboratory data) logistic regression to estimate probability of receiving PD versus HD. A comparison of IRH risk by dialysis modality was estimated using a counting-process survival model.
RESULTS: A total of 910 pairs of patients were matched by propensity scores. During a median follow-up of 2.1 years (interquartile range, 1.1-3.5 years), 341 patients were hospitalized once for an infection, 123 twice, and 106 at least three times. PD was associated with an increased risk for IRH compared with HD (propensity-matched hazard ratio [HR], 1.52). PD was associated with a reduced risk for septicemia (HR, 0.31) and pneumonia (HR, 0.58) but also an increased risk for dialysis-related infectious hospitalizations (HR, 3.44), defined as all cases of peritonitis and vascular access-related bacteremia, but not all septicemia cases.
CONCLUSIONS: PD patients are at higher risk for IRH than are HD patients. This risk is mostly explained by dialysis-related infections. However, further studies are needed to evaluate whether the severity of those hospitalizations is similar and whether this increased risk for IRH is associated with worse outcomes.

Entities:  

Mesh:

Year:  2012        PMID: 22904124      PMCID: PMC3463202          DOI: 10.2215/CJN.00440112

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  20 in total

1.  Using medical services claims to assess injuries in the elderly: sensitivity of diagnostic and procedure codes for injury ascertainment.

Authors:  R Tamblyn; T Reid; N Mayo; P McLeod; M Churchill-Smith
Journal:  J Clin Epidemiol       Date:  2000-02       Impact factor: 6.437

2.  Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study.

Authors:  Michael Allon; Thomas A Depner; Milena Radeva; James Bailey; Srinivasan Beddhu; David Butterly; Daniel W Coyne; Jennifer J Gassman; Allen M Kaufman; George A Kaysen; Julia A Lewis; Steve J Schwab
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

3.  Bacterial infections in hemodialysis patients: pathogenesis and prevention.

Authors:  Bertrand L Jaber
Journal:  Kidney Int       Date:  2005-06       Impact factor: 10.612

4.  Changing rates of stroke in the province of Quebec, Canada: 1981-1988.

Authors:  N E Mayo; M S Goldberg; A R Levy; I Danys; N Korner-Bitensky
Journal:  Stroke       Date:  1991-05       Impact factor: 7.914

5.  Septicemia in dialysis patients: incidence, risk factors, and prognosis.

Authors:  N R Powe; B Jaar; S L Furth; J Hermann; W Briggs
Journal:  Kidney Int       Date:  1999-03       Impact factor: 10.612

6.  Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations.

Authors:  Stephen P McDonald; John F Collins; Markus Rumpsfeld; David W Johnson
Journal:  Perit Dial Int       Date:  2004 Jul-Aug       Impact factor: 1.756

7.  Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Hugh C Rayner; Ronald L Pisoni; Juergen Bommer; Bernard Canaud; Erwin Hecking; Francesco Locatelli; Luis Piera; Jennifer L Bragg-Gresham; Harold I Feldman; David A Goodkin; Brenda Gillespie; Robert A Wolfe; Philip J Held; Friedrich K Port
Journal:  Nephrol Dial Transplant       Date:  2004-01       Impact factor: 5.992

8.  Quantifying the risk of infectious diseases for people with diabetes.

Authors:  Baiju R Shah; Janet E Hux
Journal:  Diabetes Care       Date:  2003-02       Impact factor: 19.112

9.  Discordance of databases designed for claims payment versus clinical information systems. Implications for outcomes research.

Authors:  J G Jollis; M Ancukiewicz; E R DeLong; D B Pryor; L H Muhlbaier; D B Mark
Journal:  Ann Intern Med       Date:  1993-10-15       Impact factor: 25.391

10.  Rates of transcervical and pertrochanteric hip fractures in the province of Quebec, Canada, 1981-1992.

Authors:  A R Levy; N E Mayo; G Grimard
Journal:  Am J Epidemiol       Date:  1995-08-15       Impact factor: 4.897

View more
  21 in total

1.  Reevaluation of ceftazidime dosing recommendations in patients on continuous ambulatory peritoneal dialysis.

Authors:  Katie E Cardone; Darren W Grabe; Evan J Zasowski; Thomas P Lodise
Journal:  Antimicrob Agents Chemother       Date:  2013-10-14       Impact factor: 5.191

2.  Outcomes of Infection-Related Hospitalization according to Dialysis Modality.

Authors:  Louis-Philippe Laurin; Hind Harrak; Naoual Elftouh; Denis Ouimet; Michel Vallée; Jean-Philippe Lafrance
Journal:  Clin J Am Soc Nephrol       Date:  2015-03-27       Impact factor: 8.237

Review 3.  Dialysis Modality and Mortality in the Elderly: A Meta-Analysis.

Authors:  Seung Seok Han; Jae Yoon Park; Soohee Kang; Kyoung Hoon Kim; Dong-Ryeol Ryu; Hyunwook Kim; Kwon Wook Joo; Chun Soo Lim; Yon Su Kim; Dong Ki Kim
Journal:  Clin J Am Soc Nephrol       Date:  2015-05-04       Impact factor: 8.237

Review 4.  Secondary Immunodeficiency Related to Kidney Disease (SIDKD)-Definition, Unmet Need, and Mechanisms.

Authors:  Stefanie Steiger; Jan Rossaint; Alexander Zarbock; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2021-12-14       Impact factor: 10.121

5.  Home versus In-Center Dialysis and Day of the Week Hospitalization: A Cohort Study.

Authors:  Karthik K Tennankore; Annie-Claire Nadeau-Fredette; Kara Matheson; Christopher T Chan; Emilie Trinh; Jeffrey Perl
Journal:  Kidney360       Date:  2021-10-22

6.  Readmissions to kidney transplantation department: incidence, causes and risk factors.

Authors:  Syrine Tlili; Lilia Ben Fatma; Ikram Mami; Hiba Ghabi; Badreddine Kaab; Smaoui Wided; Madiha Krid; Soumaya Beji; Lamia Rais; Fethi Ben Hamida; Hela Jebali; Mohamed Karim Zouaghi
Journal:  Pan Afr Med J       Date:  2022-04-14

7.  Hospitalization Rates for Patients on Assisted Peritoneal Dialysis Compared with In-Center Hemodialysis.

Authors:  Matthew J Oliver; Ahmed A Al-Jaishi; Stephanie N Dixon; Jeffrey Perl; Arsh K Jain; Susan D Lavoie; Danielle M Nash; J Michael Paterson; Charmaine E Lok; Robert R Quinn
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-27       Impact factor: 8.237

8.  Septic shock in chronic dialysis patients: clinical characteristics, antimicrobial therapy and mortality.

Authors:  Edward Clark; Anand Kumar; Amit Langote; Stephen Lapinsky; Peter Dodek; Andreas Kramer; Gordon Wood; Sean M Bagshaw; Ken Wood; Dave Gurka; Manish M Sood
Journal:  Intensive Care Med       Date:  2015-11-25       Impact factor: 17.440

9.  Comparative Study of Outcomes among Patients with Polycystic Kidney Disease on Hemodialysis and Peritoneal Dialysis.

Authors:  Ju-Yeh Yang; Likwang Chen; Chia-Ter Chao; Yu-Sen Peng; Chih-Kang Chiang; Tze-Wah Kao; Kuo-Liong Chien; Hon-Yen Wu; Jenq-Wen Huang; Kuan-Yu Hung
Journal:  Sci Rep       Date:  2015-08-06       Impact factor: 4.379

10.  Association between acetylsalicylic acid and the risk of dialysis-related infections or septicemia among incident hemodialysis patients: a nested case-control study.

Authors:  Hind Harrak; Isabelle Normand; Rachel Grinker; Naoual Elftouh; Louis-Philippe Laurin; Jean-Philippe Lafrance
Journal:  BMC Nephrol       Date:  2015-07-28       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.